… the efficacy, safety and tolerability of valsartan to an angiotensin-converting enzyme (ACE)
inhibitor, lisinopril, and placebo in patients with mild-to-moderate essential hypertension. …

… Six hundred outpatients aged between 22 and 84 years with essential hypertension (… trial
with dose titration to assess the safety, tolerability, and efficacy of isradipine in doses of 1.25, …

… that directly compare the efficacy and safety profile of manidipine with that of amlodipine,
one of the most widely used calcium antagonists for the treatment of arterial hypertension (12) . …

The long-term safety data on angiotensin II receptor blockers in combination with thiazide
diuretics are limited. The present study reports on the long-term efficacy, safety, and tolerability …

… In conclusion, the clinical profile of barnidipine in patients with mild to moderate hypertension
shows the high level of efficacy, tolerability and safety predicted by its pharmacological …

… the anti-hypertensive efficacy and safety of nebivolol (5 mg once daily) and lisinopril (20
mg once daily) given for 12 weeks in patients with mild to moderate essential hypertension. …

… purpose of the current study was to determine the efficacy and safety of graded doses of
valsartan compared placebo in the treatment of patients stages 1 to 3 essential hypertension. …

… Overall, 93.3% of patients were diagnosed with essential hypertension and 6.7% with
secondary hypertension. All patients were co-diagnosed with DM. Nebivolol therapy was …

… Arterial hypertension is one of the main risk factors related to … from primary hypertension.
According to the Guidelines of the Deutsche Hochdruckliga eV (DHL) (German Hypertension …

… parallel-group study comparing the efficacy and safety of azilsartan and candesartan cilexetil
(candesartan) in Japanese patients with grade I or II essential hypertension. In addition, the …